Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

13%

1 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A

6(75.0%)

Phase 1

1(12.5%)

Phase 4

1(12.5%)

8Total

N/A(6)

Phase 1(1)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT06263985Phase 4Active Not Recruiting

Axis(TM) Solvent-dehydrate Dermal Allograft in the Treatment of Pelvic Organ Prolapse.

Role: lead

NCT06225375Phase 1Unknown

Flat Polypropylene Mesh in the Treatment of Uterine and Recurrent or Advanced Pelvic Organ Prolapse

Role: lead

NCT03842410Not ApplicableUnknown

Solyx Single-Incision SlingDynamic Intraoperative Standing Sling Technique (DISST) as an Office-based Procedure

Role: lead

NCT02921451Not ApplicableUnknown

Prospective Analysis of Restorelle in the Treatment of Uterine Prolapse

Role: lead

NCT03331328Not ApplicableCompleted

MonaLisa Touch Randomized Double-Blind Placebo Controlled Study

Role: lead

NCT03271294Not ApplicableCompleted

Prospective Performance Analysis of the Exair(TM) Prolapse Repair System in the Treatment of Pelvic Organ Prolapse

Role: lead

NCT01137539Not ApplicableCompleted

TVT-SECUR as an Office-based Procedure

Role: lead

NCT03120117Not ApplicableUnknown

Importance of Patient Positioning at Cough Test When Considering Success Following Sling Procedures

Role: lead

All 8 trials loaded